Israel Corporation Ltd. Financial Results for Q2 2025
Israel Corporation Ltd. (TASE: ILCO) has recently published its financial results for the second quarter of 2025, covering the period up to June 30, 2025. The company highlighted several key financial figures, showcasing a variety of metrics reflecting its ongoing strategy and performance.
Selected Financial Highlights
During the second quarter of 2025, Israel Corporation reported significant results that are worth noting. The financial figures are presented in millions:
Performance Metrics
For the quarter, the company's share of profits from several associated companies was as follows:
- ILCO share in ICL profit: $40 million compared to $50 million in the previous year.
- ILCO share in Prodalim profit: $2 million; the previous year showed no profit.
- Financing, General & Administrative expenses at HQ: $2 million, contrasting with a $1 million loss reported last year.
- Net profit attributed to company shareholders: $43 million, a decrease from $48 million in the second quarter of the previous year.
Liquidity Status and Financial Assets
As of June 30, 2025, Israel Corporation's liquidity standing showed that total financial liabilities reached $715 million, with liquid asset investments amounting to $739 million, which included $8 million in pledged deposits. The net cash, including the fair value of derivatives, was reported at $26 million. This shows an improvement compared to $21 million recorded on March 31, 2025.
Investment Updates
In March, Israel Corporation completed a significant investment agreement with Prodalim Investments Ltd., increasing its stake to approximately 27.5% of Prodalim's share capital. Prodalim specializes in innovative natural solutions across various sectors, including beverage bases and functional ingredients. This partnership aligns with Israel Corporation's focus on growth and diversification.
Future Strategies and Dividends
On March 27, 2025, the Board of Directors declared a dividend of $15 million, adhering to its established dividend policy. This reflects Israel Corporation's commitment to maintaining shareholder value while pursuing strategic investments in sectors such as food technology, agriculture, and healthcare.
Looking ahead, Israel Corporation continues to focus on maximizing returns through active engagement with its portfolio companies, including ICL Group (NYSE: ICL), where it holds about 44%, and AKVA Group, with an 18% stake. These strategic holdings are an integral part of the company's future growth trajectory.
About Israel Corporation
Israel Corporation Ltd. is a prominent public investment firm dedicated to owning and managing high-quality companies with proven management and market strategies. The corporation has pursued an updated strategy since 2019, intending to expand its portfolio through investments concentrated in diverse growth sectors.
Israel Corporation is publicly listed on the Tel Aviv Stock Exchange under the ticker ILCO and is also part of the TA-35 Index. The company aims to leverage its managerial expertise to foster innovation and drive profitability in its investments.
Frequently Asked Questions
What is the primary business focus of Israel Corporation?
Israel Corporation focuses on high-quality investments, particularly in the food technology, agriculture, and healthcare sectors.
What were the net profits reported for Q2 2025?
The net profit attributed to Israel Corporation's shareholders was reported at $43 million.
What significant investment did Israel Corporation make?
The corporation increased its stake in Prodalim Investments Ltd. to approximately 27.5% of its share capital, focusing on natural solutions.
How does Israel Corporation manage its investments?
Israel Corporation utilizes active board participation and management expertise to optimize its investment returns.
What is Israel Corporation's approach to dividends?
The company has committed to a policy of distributing dividends, recently declaring $15 million in dividends in line with its policy.
